Your Chief AI Officer · Monday, November 9, 2026 · Heard on the podcasts
Peter Attia says labs reveal about a third of what clinicians need
Heard1 sourceFor patients
On The Peter Attia Drive episode #415, Peter Attia said he tells patients that labs reveal roughly a third of what his team wants to know, maybe 25%. He said healthspan dimensions such as strength, cognition and emotional health mostly cannot be captured in a blood draw, and stressed longitudinal data over single snapshots.
On episode #415 of The Peter Attia Drive, an Ask Me Anything installment devoted to lab testing, Peter Attia described what he tells patients at the end of a first lab review: the panel shows "roughly a third of what we care to know about you, maybe a bit less, maybe 25%." He called that "a very important 25%" but said his team still has "a lot of work to do" to understand risk. His argument is that labs feel complete because they are objective, numerical and come with reference ranges, and that a result inside the range is often read as "all systems are go" when it is not. He said direct to consumer testing has reinforced that belief.
Attia frames health around longevity as the product of lifespan and healthspan. On the healthspan side he named physical function (strength, endurance, mobility, freedom from pain), cognitive function (processing speed, memory, executive function) and emotional health (purpose, relationships, resilience), and said these mostly cannot be captured in a blood draw. He also stressed longitudinal data over single snapshots. In his example from the episode, a high sensitivity C reactive protein of 3 means something different for a patient whose baseline is 0.5 than for one who has always run high, and a single reading cannot separate lab error, a recent illness or a chronic pattern.
For medical, wellness and longevity practices, this matters because many assessment offerings are built and marketed around the lab panel. If the panel is presented as the report card, patients may leave with false reassurance and clinicians may lack the trend data needed to act. For AI leaders, the point is about inputs: models and dashboards built on one-time lab values inherit the same blind spots.
The evidence is limited. This is one physician's view, stated on a podcast. No study is cited for the share of information labs provide, and the 25% to 33% range is a clinical rule of thumb, not a measured figure. The show also carries a disclaimer that it is not medical advice.
The move: ask your clinical and data teams whether your assessment programs capture functional, cognitive and emotional measures alongside labs, whether they keep longitudinal baselines patients can be compared against, and whether patient-facing materials describe what a panel can and cannot show. The return is clearer conversations for clinicians and more accurate expectations for patients.
Ask your team. Ask your team whether your assessment programs track functional and cognitive measures and keep longitudinal baselines, not only single lab panels.
Run this
The prompt to act on this item, for your own model.
Paste it into Claude, ChatGPT or Copilot and fill the bracketed slots with your own numbers. The output is a draft for your team to check, built only from the sources on this page. Never paste patient data. How these prompts are written.
You are a clinical operations advisor to the Chief Medical Officer and physician leaders of [your organization], a medical, health or wellness practice that offers assessment programs. Context: On The Peter Attia Drive, episode #415, AMA #91: Understanding lab testing: what blood work can and cannot tell you about your health and disease risk, Peter Attia said he tells patients a first lab panel shows "roughly a third of what we care to know about you, maybe a bit less, maybe 25%." He said healthspan dimensions, namely physical function, cognitive function and emotional health, mostly cannot be captured in a blood draw, and he stressed longitudinal data over single snapshots. His example: a high sensitivity C reactive protein of 3 means something different for a patient whose baseline is 0.5 than for one who has always run high. He argued lab testing is often oversold as a complete report card on health. This is one physician's view, stated on a podcast. No study is cited for the share of information labs provide, and the range is a clinical rule of thumb, not a measured figure. Task: Draft a question set I can bring to our clinical and data teams to test whether [your assessment programs] track functional, cognitive and emotional measures alongside labs, keep longitudinal baselines patients can be compared against, and describe in patient-facing materials what a panel can and cannot show. Output: A one-page memo for the executive team with these sections: Why we are asking; Questions for the clinical team; Questions for the data team; Questions about patient-facing materials; What we must verify before acting. Use what I fill in here: measures we track today beyond labs [list them]; where results are stored [your EHR or data system]; how far back our baseline data goes [your baseline history]; who owns each program [program owners]. Guardrails: Use only the facts above and the slots I filled. Cite The Peter Attia Drive by name for any claim from it. Flag anything uncertain or that needs verifying. Do not request or include patient data. Nothing here is medical advice. State at the top that this is a draft for the team to check.
- The claim.
- Attia says lab testing is often oversold as a complete report card on health.
- The evidence.
- Said on a podcast; no study is cited for the share of information labs provide.
By seat
For the Chief AI Officer. Check that patient data platforms store results longitudinally so AI tools can read trends, not snapshots.
For the Chief Medical Officer and physicians. Review how clinicians set patient expectations about what lab panels can show.
For the Patient experience. Give patients a clear explanation that lab results are one input among several.
Checked before publishing. 2 independent outlets. 1 figure matched to the source text. Also reported by MJH Life Sciences.
Sources
Drafted by Lumen from the sources above, scored by a second pass on six criteria, then checked by rule against those sources (every figure, two independent outlets or a primary source) and published only when it passes. A person can pull any item, and corrections are published here. Apolitical, always. Nothing here is medical advice. How Your Chief AI Officer is made.